Immunoprotective factors in breast milk and sera of mother-infant pairs. 1986

O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom

We analysed breast milk and serum samples from 33 healthy Nigerian mother-infant pairs for concentrations of IgG, IgM, IgA, C3, C4 and lysozyme. We found that the mean IgG and IgM concentrations in maternal sera were three to four times higher than the levels in infant sera, and five to ten times higher than in breast milk. The IgA and lysozyme concentrations in breast milk were, however, slightly higher than the levels in infant sera, suggesting an active localized synthesis of these factors in the mammary gland. While 54.5% of the milk samples lacked measurable concentrations of IgM by radial immunodiffusion, IgA was consistently present in all the milk samples. The mean C3 concentration in maternal sera was 164 mg/100 ml, compared to 145 mg/100 ml and 11.5 mg/100 ml in infant sera and breast milk respectively. The C4 concentration was also considerably lower in breast milk than in maternal and infant sera.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008895 Milk, Human Milk that is produced by HUMAN MAMMARY GLANDS. Breast Milk,Human Milk,Milk, Breast
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3

Related Publications

O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
April 2002, Early human development,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
June 2000, Journal of tropical pediatrics,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
September 1996, The Journal of infectious diseases,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
January 2018, F1000Research,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
February 2009, The Journal of clinical psychiatry,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
April 2018, The Journal of antimicrobial chemotherapy,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
June 1992, The Pediatric infectious disease journal,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
September 2021, Antimicrobial agents and chemotherapy,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
October 2006, British journal of clinical pharmacology,
O O Kassim, and O Afolabi, and K A Ako-Nai, and S E Torimiro, and G K Littleton, and C N Mbogua, and O Oke, and W Turner, and F Grissom
January 2023, Frontiers in microbiology,
Copied contents to your clipboard!